Loading viewer...
investor_presentation
Format: PDF investor_presentation
Moderna presented its digital investor event on November 8, 2023, discussing the potential of its mRNA platform and applications of artificial intelligence for scaling. The presentation outlined plans to launch up to 15 products within the next 5 years and advance individualized neoantigen therapy for cancer treatment.
conference
25 Pages
investor_presentation
13 Pages
Welspun Specialty Solutions Limited
investor_presentation
Invitae Corporation